Literature DB >> 18700887

Association between serum lipoprotein (a) level and progression of non-proliferative diabetic retinopathy in Type 2 diabetes.

Hideharu Funatsu1, Erika Shimizu, Hidetaka Noma, Tatsuya Mimura, Sadao Hori.   

Abstract

PURPOSE: To investigate independent risk factors related to the progression of non-proliferative diabetic retinopathy (NPDR) for Japanese Type 2 diabetic patients.
METHODS: One hundred and six patients with NPDR were followed up for 2 years. Diabetic retinopathy (DR) was determined by colour fundus photography. Multivariate logistic regression analysis was performed to assess variables independently associated with the progression of NPDR. Serum concentrations of novel risk factors for atherosclerotic vascular disease, including lipoprotein (a) [Lp(a)] and fibrinogen, were measured.
RESULTS: Thirty-three patients (31%) had progressed by two scale steps or more in 2 years. The progression of NPDR was significantly associated with HbA(1c) [odds ratio (OR) 2.12; 95% confidence interval (CI) 1.14-4.87], systolic blood pressure (OR 1.72; 95% CI 1.14-2.91), Lp(a) (OR 2.70; 95% CI 1.09-5.12) and fibrinogen (OR 1.68; 95% CI 1.03-3.08). Multivariate logistic regression analysis showed that HbA(1c) (OR 1.74; 95% CI 1.12-3.21) and Lp(a) level (OR 1.90; 95% CI 1.06-4.33) were significant and independent predictors of the progression of NPDR.
CONCLUSION: These data suggest that serum Lp(a) level is an independent risk factor for the progression of NPDR in Type 2 diabetes patients. We recommend that further prospective validation of our findings be undertaken to confirm these observations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18700887     DOI: 10.1111/j.1755-3768.2008.01298.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  Serum lipoprotein(a) levels are greater in female than male patients with type-2 diabetes.

Authors:  Manouchehr Nakhjavani; Afsaneh Morteza; Alireza Esteghamati; Omid Khalilzadeh; Ali Zandieh; Reza Safari
Journal:  Lipids       Date:  2010-12-14       Impact factor: 1.880

Review 2.  Lipoprotein(a) and Arterial Stiffness Parameters.

Authors:  Alexander Sorokin; Kazuhiko Kotani
Journal:  Pulse (Basel)       Date:  2015-08-25

Review 3.  Epidemiological issues in diabetic retinopathy.

Authors:  Peter H Scanlon; Stephen J Aldington; Irene M Stratton
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

4.  Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea.

Authors:  Jae Seung Yun; Tae Seok Lim; Seon Ah Cha; Yu Bae Ahn; Ki Ho Song; Jin A Choi; Jinwoo Kwon; Donghyun Jee; Yang Kyung Cho; Yong Moon Park; Seung Hyun Ko
Journal:  Diabetes Metab J       Date:  2016-10-05       Impact factor: 5.376

5.  Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy.

Authors:  Byung Ju Jung; Mee Yon Lee; Sohee Jeon
Journal:  J Ophthalmol       Date:  2019-07-17       Impact factor: 1.909

6.  Correlation between Imaging Morphological Findings and Laboratory Biomarkers in Patients with Diabetic Macular Edema.

Authors:  Eleni Dimitriou; Theodoros N Sergentanis; Vaia Lambadiari; George Theodossiadis; Panagiotis Theodossiadis; Irini Chatziralli
Journal:  J Diabetes Res       Date:  2021-08-13       Impact factor: 4.011

7.  LPA Genotypes and Haplotypes Are Associated with Lipoprotein(a) Levels but Not Arterial Wall Properties in Stable Post-Coronary Event Patients with Very High Lipoprotein(a) Levels.

Authors:  Andreja Rehberger Likozar; Aleš Blinc; Katarina Trebušak Podkrajšek; Miran Šebeštjen
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.